-
Beacon Stories
-
Eye On the Cure Research News
ProQR Completes Enrollment in Phase 2/3 Clinical Trial of RNA Therapy for LCA10
-
Eye On the Cure Research News
REGENXBIO’s Gene Therapy for Wet AMD Performing Encouragingly in Human Study
-
Eye On the Cure Research News
Penn Vet’s William Beltran Elected to the National Academy of Medicine
-
Beacon Stories

Our Track Record
The Foundation is committed to finding treatments and cures for people affected by blinding retinal diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$800M dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
82 grants awarded
in 2020 – over 90 investigators, 67 institutions
Learn more
The Foundation in the News
ProQR Completes Enrollment in Phase 2/3 Clinical Trial of RNA Therapy for LCA10
-
Jan 11, 2021 Beacon Stories
-
Jan 7, 2021 Eye On the Cure Research News
-
Dec 21, 2020 Beacon Stories

Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now

Welcome to the new Foundation site — supported in partnership with Genentech, A Member of the Roche Group